A Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics Following Multiple Ascending Doses of Tramadol Hydrochloride in Healthy Male and Female Subjects
Phase of Trial: Phase I
Latest Information Update: 13 Jul 2018
At a glance
- Drugs Tramadol (Primary)
- Indications Pain
- Focus Adverse reactions
- 13 Jul 2018 According to a Bausch Health Companies media release, Valeant Pharmaceuticals International changed its name to Bausch Health Companies.
- 01 Dec 2017 Results published in the Clinical Pharmacology in Drug Development
- 09 Jan 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.